DBD vs PLUS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 30, 2026
DBD
PLUS
Investment Advisor Scores
PLUS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | DBD | PLUS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 12.1655 | 17.1527 | DBD |
| PEG Ratio | 0 | 1.0714 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 1.7% | 1.0% | DBD |
| Earnings Growth | 34.2% | -28.0% | DBD |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 38.7/100 | 44.9/100 | PLUS |
| Profit Margin | 2.9% | 4.9% | PLUS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | PLUS |
Relative Price Performance (Last 90 Days)
Current Technical Phase
DBD
MarkdownPrice below a falling SMA50 (slope -10.6%), weak momentum, RSI 42
PLUS
MarkupPrice above SMA50, rising 50-day trend (2.6% over 20 days), RSI 59
Fundamentals Snapshot
| Metric | DBD | PLUS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.0 | 16.8 |
| Trailing P/E | 20.3 | 19.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.0% |
| Gross Margin | 0.3% | 0.3% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 3.02 | 4.66 |
| Dividend Yield | — | 0.01% |